TSXV:CLAS.H - Post by User
Post by
Dude51on Jun 02, 2020 7:11am
127 Views
Post# 31100189
Somebody said broke, going to delist, blah blah
Somebody said broke, going to delist, blah blahOh look another patent application:
020-06-02 04:00 PT - News Release
SAN FRANCISCO, June 02, 2020 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTC: KALTF) (the "Company" or "Kalytera") today announced that Salzman Group, Inc. has filed a provisional patent application protecting the use of its proprietary, liquid, nitric oxide donor, R-107, for therapy of coronavirus and COVID-19 associated pneumonia. If granted, the patent would offer exclusivity to Salzman Group for the use of this agent in the prevention and treatment of coronavirus-associated and COVID-19 lung infections and acute lung injury until 2041, with potentially extended coverage until 2046 in the USA to compensate for clinical development activity as provided by the Hatch-Waxman Act.
Knock knock, who's there? Alice...